Asb Consultores, LLC Bristol Myers Squibb CO Transaction History

Asb Consultores, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $393,436 - $446,080	8,200 New	8,200 $444,000
Q3 2023 Nov 28, 2023	SELL	$57.89 - $64.73 $187,274 - $209,401	-3,235 Reduced 30.53%	7,361 $427,000
Q2 2023 Aug 07, 2023	BUY	$63.71 - $70.74 $19,750 - $21,929	310 Added 3.01%	10,596 $677,000
Q1 2023 May 03, 2023	BUY	$65.71 - $74.53 $102,573 - $116,341	1,561 Added 17.89%	10,286 $712,000
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $35,541 - $42,085	519 Added 6.32%	8,725 $627,000
Q3 2022 Jan 11, 2023	BUY	$0.13 - $76.84 $76 - $45,181	588 Added 7.72%	8,206 $583,000
Q2 2022 Jan 11, 2023	BUY	$72.62 - $79.98 $8,423 - $9,277	116 Added 1.55%	7,618 $587,000
Q1 2022 Jan 11, 2023	BUY	$61.48 - $73.72 $461,222 - $553,047	7,502 New	7,502 $548,000
Q4 2021 Jan 11, 2023	SELL	$53.63 - $62.52 $8,366 - $9,753	-156 Reduced 1.9%	8,050 $502,000

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Asb Consultores, LLC, based on Form 13F filings with the SEC.

Stay updated on Asb Consultores, LLC with notifications on news.